Tetsuo Ashizawa
Neurology · Gainesville, FLNPI 1093873754
Payments from drug & device makers
Across 40 payments — averaging $9601.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$275K
- Biohaven Pharmaceutical Holding Company Ltd.$81K
- Biohaven Pharmaceuticals, Inc.$27K
- Mitsubishi Tanabe Pharma Holdings America, Inc.$500
- Arbor Pharmaceuticals, Inc.$65
- Acorda Therapeutics, Inc$62
- plus $303 from 11 others
Across 1 payment — averaging $2825.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$3K
What the payments were for
- Consulting fees$50048%
- Speaking & faculty fees$626%
- Food & beverage$48046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$384,075 in reported general payments places this provider in the 90th percentile of 1,434 neurology providers in Florida.
Other neurology in Gainesville
- Torge RempeGainesville$3.6M
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.